AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Frey-Met G1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Freyn Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Frey-Met G1 Tablet SR

GlucoTwin SR tablets are classified as antidiabetic medications, a dual-drug formulation for managing type 2 diabetes in adults. They help regulate blood glucose levels. GlucoTwin SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring is necessary, and your doctor might recommend blood tests to assess blood cell counts and liver function.

Uses of Frey-Met G1 Tablet SR

Managing type 2 diabetes

Major Benefits of Frey-Met G1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Frey-Met G1 Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. This medication should be administered with food.

Common Side effects of Frey-Met G1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Frey-Met G1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Frey-Met G1 Tablet SR should be administered with a meal.

How Frey-Met G1 Tablet SR works:

Frey-Met G1 SR tablets contain a dual antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Frey-Met G1 Tablet SR is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Frey-Met G1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Frey-Met G1 tablets are contraindicated for breastfeeding mothers. Evidence indicates a potential risk of infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Frey-Met G1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Frey-Met G1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Frey-Met G1 Tablet SR to individuals with hepatic impairment. Dosage modification of Frey-Met G1 Tablet SR may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, Frey-Met G1 Tablet SR should typically be initiated at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Frey-Met G1 Tablet SR :

Should you forget a dose of Frey-Met G1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Frey-Met G1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Frey-Met G1 Tablet SR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Frey-Met G1 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Frey-Met G1 Tablet SR and seek immediate medical attention.
Frey-Met G1 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with a healthy diet and regular exercise. Glimepiride boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Frey-Met G1 Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Frey-Met G1 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually by some researchers.
Frey-Met G1 Tablet SR can cause low blood sugar (hypoglycemia), leading to symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Frey-Met G1 Tablet SR and alcohol is unsafe. Alcohol can worsen the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Frey-Met G1 Tablet SR
53
MRP 65
18% off